"Rank","Title","Status","Study Results","Conditions","Interventions","Locations","URL"
1,"Inactivated Influenza A/H9N2 Vaccine With and Without MF59 Adjuvant in Ambulatory Adults","Completed","No Results Available","Influenza","Biological: Influenza A/H9N2 vaccine|Drug: MF59 adjuvant","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00133471"
2,"A Safety and Immunogenicity Trial in Adults 65 Years of Age or Over to Prevent Influenza","Completed","No Results Available","Influenza","Biological: AVX502|Biological: Placebo","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00706732"
3,"A Phase 1/2 Clinical Trial of an Alphavirus Replicon Vaccine for Influenza","Completed","No Results Available","Influenza","Biological: AVX502|Biological: Placebo","Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00440362"
4,"Safety and Immunogenicity of Inactivated Influenza Virus Vaccine Among Healthy Children 6-12 Weeks of Age","Completed","No Results Available","Inactivated Influenza Vaccine","Biological: 2005-2006 trivalent inactivated influenza vaccine","Seattle Children's Hospital and Regional Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00242424"
5,"Influenza Immunity Against Pandemic Respiratory Virus","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Stanford University, Stanford, California, United States","https://ClinicalTrials.gov/show/NCT00138281"
6,"St. Jude Open Label H5 Trial","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","St. Jude Children's Research Hospital, Memphis, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00311675"
7,"Higher Dose Intradermal H5 Vaccine","Completed","Has Results","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1|Drug: Placebo (IM)|Drug: Placebo (ID)","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00439335"
8,"Proteomic Profiling for Influenza Vaccination - FluMist","Completed","No Results Available","Influenza","Biological: FluMist","Eastern Virginia Medical School, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00385281"
9,"Interferon as a Mucosal Adjuvant for Influenza Vaccine Given Intranasally","Completed","Has Results","Influenza","Biological: Trivalent inactivated influenza virus vaccine (2006-2007 formulation)|Biological: Type 1 interferon","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00436046"
10,"Immunogenicity and Safety of Different Doses of Fluzone® Influenza","Completed","No Results Available","Influenza","Biological: Fluzone® (IM)|Biological: Fluzone®","Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00253734"
11,"Revaccination With Subunit Influenza A/Vietnam/1203/2004 (H5N1) Vaccine","Completed","No Results Available","Influenza","Biological: Influenza A/Vietnam/1203/2004 (H5N1; sanofi pasteur)","University of Rochester, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240903"
12,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Split, Inactivated, Trivalent Influenza vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00743275"
13,"A Study to Evaluate the Safety and Immune Responses to Fluzone® Vaccination","Completed","Has Results","Influenza","Biological: Influenza virus vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00835926"
14,"Phase IV Trial to Determine the Safety and Immunogenicity of the WHO Formulation of the 2006-2007 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (2006-2007 Fluzone® vaccine)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00389532"
15,"Safety and Immunogenicity of the 2005-2006 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza Virus Vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258830"
16,"Safety and Immunogenicity of the World Health Organization (WHO) Formulation of the 2004-2005 Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: Fluzone®: Influenza virus vaccine 2004-2005 formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831987"
17,"Study to Collect Sera for Immunogenicity Testing in Children Vaccinated With Fluzone®","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (Pediatric formulation)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00836953"
18,"Phase IV Trial to Collect Safety Data and Sera in Healthy Children Given Fluzone Vaccine","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00258817"
19,"Trial to Describe the Safety and Immunogenicity of Fluzone®","Completed","Has Results","Influenza","Biological: Inactivated, Split-Virion Influenza Virus","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00524940"
20,"Study of Safety and Immunogenicity of Fluzone® in Healthy Children","Completed","Has Results","Influenza","Biological: Influenza Vaccine 2004-2005 Paediatric Formulation","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00831675"
21,"Phase IV Trial to Collect Safety Data and Sera for Immunogenicity Testing in Healthy Children Given Fluzone® Vaccine","Completed","Has Results","Influenza","Biological: 2007-2008 Influenza Virus Vaccine","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00561002"
22,"Trivalent Baculovirus-expressed Influenza HA Vaccine in Adults With Non-Hodgkin's B-cell Lymphoma","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine|Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","University of Texas MD Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307177"
23,"Half vs Full Dose Influenza Vaccine","Completed","No Results Available","Influenza","Biological: Fluzone® (Aventis Pasteur inactivated influenza vaccine)","Pentagon, Washington, District of Columbia, United States|Walter Reed Army Medical Center, Washington, District of Columbia, United States","https://ClinicalTrials.gov/show/NCT00283283"
24,"Phase II Study to Investigate the Kinetics of the Immune Response Generated by Influenza Virus Vaccine.","Completed","No Results Available","Influenza","Biological: CAIV-T|Biological: TIV|Biological: Placebo","David M. Radin, MD, Stamford, Connecticut, United States","https://ClinicalTrials.gov/show/NCT00192309"
25,"REDucing Influenza Among University Students, University of California at Berkeley","Completed","No Results Available","Influenza-like Illness|Influenza","Behavioral: Online education","University of California, Berkeley, Berkeley, California, United States","https://ClinicalTrials.gov/show/NCT00448773"
26,"Inactivated Influenza Vaccine in Infants 10-22 Weeks of Age","Completed","No Results Available","Influenza","Biological: Fluzone","Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231920"
27,"Phase I Safety and Immunogenicity Study of VAX102 [Flagellin.HuM2e] Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza Infection","Biological: VAX102 [Flagellin.HuM2e]|Biological: Placebo","Johnson County Clinical Trials, Lenexa, Kansas, United States|Sealy Vaccine Center, UTMB, Galveston, Texas, United States","https://ClinicalTrials.gov/show/NCT00603811"
28,"Safety, Reactogenicity and Immunogenicity of an H5N1 VLP","Completed","No Results Available","Pandemic Influenza","Biological: H5N1 VLP Vaccine|Biological: Placebo","Healthcare Discoveries, Inc., San Antonio, Texas, United States","https://ClinicalTrials.gov/show/NCT00519389"
29,"Safety and Immune Response to Recombinant Live-Attenuated Influenza H2N2 Virus Vaccine","Completed","No Results Available","Influenza|Virus Diseases","Biological: H2N2 1960 AA ca recombinant vaccine","Johns Hopkins Bayview Medical Center, CIR Unit at the Mason F Lord Building, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00722774"
30,"Safety of and Immune Response to Recombinant Live-Attenuated Influenza H6N1 Virus Vaccine Vaccine","Completed","No Results Available","Influenza|Virus Diseases","Biological: H6N1 Teal HK 97/AA ca recombinant vaccine","Johns Hopkins Bayview Medical Center, CIR Unit at the Mason F Lord Building, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00734175"
31,"Study to Determine a Preference for Fluzone Vaccine Given Intradermally (ID) and Intramuscularly (IM) in Healthy Adults","Completed","Has Results","Influenza","Biological: Fluzone: Influenza virus vaccine","Grove City, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00623181"
32,"H9 Priming Study in Healthy Adults","Completed","No Results Available","Influenza","Biological: Subvirion inactivated influenza A/H9N2 (G9 variant) vaccine","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00617331"
33,"H5N1 Vaccine Intramuscular Versus Intradermal in Healthy Adults","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00310206"
34,"Trial to Collect Safety Data and Sera for Immunogenicity Testing","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine (Fluzone®)","Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00389857"
35,"Safety and Efficacy Study of Fluzone® Vaccine Combined With Different Doses of JVRS-100 Adjuvant","Completed","No Results Available","Influenza","Biological: Fluzone vaccine with JVRS-100 adjuvant|Biological: Fluzone vaccine","Miami Research Associates, Miami, Florida, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States","https://ClinicalTrials.gov/show/NCT00662272"
36,"Trial to Investigate Immune Responses Elicited by a Liquid Formulation of Influenza Virus Vaccine (CAIV-T) in Healthy Children","Completed","No Results Available","Influenza","Biological: CAIV-T 10^7|Biological: CAIVT 10^5|Biological: Placebo|Biological: TIV","Suncoast Clinical Research, Inc., New Port Richey, Florida, United States|Division of Allergy Immunology and Infectious Disease, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00192322"
37,"Open Label Evaluation of H5N1 Vaccine at Vaccine Manufacturing Facilities","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A Vaccine A/H5N1","Sanofi Pasteur, Swiftwater, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00311649"
38,"Safety and Dose Study of Peramivir for Influenza Treatment","Completed","No Results Available","Influenza","Drug: Peramivir","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States","https://ClinicalTrials.gov/show/NCT00297050"
39,"Single Group Study of the Safety of and Immune Response to a Bird Flu Vaccine (H7N3) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: Live Influenza A Vaccine H7N3 (6-2) AA ca Recombinant (A/chicken/British Columbia/CN-6/2004 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, 4940 Eastern Avenue, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00516035"
40,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study B)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/Chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Center for Immunization Research Inpatient Unit, Mason F. Lord Building, Johns Hopkins Bayview Medical Center, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00380237"
41,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H5N1) in Healthy Adults","Completed","No Results Available","Influenza|Virus Diseases","Biological: H5N1 (6-2) AA ca Recombinant (A/VietNam/1203/2004 x A/AnnArbor/6/60/ca)","Center of Immunization Research (CIR), Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00347672"
42,"Safety of and Immune Response to a Bird Flu Virus Vaccine (H9N2) in Healthy Adults (Study A)","Completed","No Results Available","Influenza|Virus Diseases","Biological: H9N2 (6-2) AA ca Reassortant (A/chicken/Hong Kong/G9/97 x A/Ann Arbor/6/60 ca)","Johns Hopkins School of Public Health, Baltimore, Maryland, United States","https://ClinicalTrials.gov/show/NCT00110279"
43,"Study to Evaluate the Effectiveness of FluMist Vaccination in a School-Based Intervention Program","Completed","No Results Available","Influenza","Biological: FluMist","Division of General Pediatrics, University of Maryland School of Medicine, Baltimore, Maryland, United States|Division of Allergy and Infectious Diseases, University of Washington School of Medicine, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00192218"
44,"Evaluation of Alternative Oseltamivir (Tamiflu) Dosing Strategies.","Completed","No Results Available","Influenza","Drug: Oseltamivir|Drug: Probenecid","VA Palo Alto Health Care System, Palo Alto, California, United States","https://ClinicalTrials.gov/show/NCT00304434"
45,"Immunogenicity and Safety of Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant Hemagglutinin","Rochester Medical Center, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|University of Virginia Health System, Charlottesville, Virginia, United States","https://ClinicalTrials.gov/show/NCT00328107"
46,"Immunogenicity and Safety of FluBlok Trivalent Recombinant Hemagglutinin Influenza Vaccine in Healthy Pediatrics","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Kentucky pediatric /Adult Research, Bardstown, Kentucky, United States|Saint Louis University, Saint Louis, Missouri, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00336453"
47,"Single Dose Escalating Study of DAS181 in Adults","Completed","No Results Available","Influenza","Drug: DAS181|Drug: Placebo","Comprehensive Phase One, Miramar, Florida, United States","https://ClinicalTrials.gov/show/NCT00527865"
48,"Open-Label Study of H5 Vaccine in Participants of Protocol 04-077","Completed","Has Results","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States","https://ClinicalTrials.gov/show/NCT00402649"
49,"Pandemic Influenza Plasmid DNA Vaccines (Needle)","Completed","No Results Available","Influenza","Biological: VCL-IPT1|Biological: VCL-IPM1|Biological: PBS","Accelovance, San Diego, California, United States|SNBL, Baltimore, Maryland, United States|SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00709800"
50,"A Prospective Study to Evaluate the Safety of a New Trivalent Intranasal Influenza Vaccine","Completed","Has Results","Influenza","Biological: Trivalent influenza virus vaccine|Biological: Placebo","Covance, Daytona Beach, Daytona Beach, Florida, United States|Covance, Portland, Portland, Oregon, United States|Covance, Austin, Austin, Texas, United States","https://ClinicalTrials.gov/show/NCT00677820"
51,"Pandemic Influenza Plasmid DNA Vaccines (Needle-Free)","Completed","No Results Available","Influenza","Biological: VCL-IPM1|Biological: VCL-IPT1|Biological: PBS","Accelovance, San Diego, California, United States|SNBL, Baltimore, Maryland, United States|SUNY at Stonybrook, Stony Brook Medical Center, Stony Brook, New York, United States","https://ClinicalTrials.gov/show/NCT00694213"
52,"A Phase I Safety and Immunogenicity Study of Mix and Match of Licensed Flu Vaccine and Flumist","Completed","No Results Available","Influenza","Biological: FluMist|Biological: Fluzone","Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00231907"
53,"Influenza Vaccination in Patients Receiving Antineoplastic Therapy for Non-Hodgkin's Lymphoma","Completed","No Results Available","Lymphoma","Biological: Trivalent Baculovirus-expressed Influenza HA vaccine","U.T.M.D. Anderson Cancer Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00307710"
54,"Inactivated Influenza A/H5N1 Vaccine in the Elderly","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00230750"
55,"H5 Booster After a Two Dose Schedule","Completed","No Results Available","Influenza","Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States","https://ClinicalTrials.gov/show/NCT00240968"
56,"H5 Adult - Chiron Study of Bird Flu Vaccine","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (Chiron)|Biological: MF-59|Drug: Placebo","Stanford University, Stanford, California, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States","https://ClinicalTrials.gov/show/NCT00280033"
57,"Study to Evaluate the Safety of a Monovalent Vaccine of a New 6:2 Reassortant in Healthy Adults (AV024)","Completed","No Results Available","Influenza","Biological: AV024|Other: Placebo","SFBC International Inc, Miami, Florida, United States","https://ClinicalTrials.gov/show/NCT00240877"
58,"H5 Vaccine Alone or With Adjuvant in Healthy Adults","Completed","No Results Available","Influenza","Drug: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur pre-adsorbed)","University of Maryland Baltimore, Baltimore, Maryland, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00296634"
59,"A/H5N1 Vaccine in Healthy Children Aged 2-9 Years","Completed","No Results Available","Influenza","Biological: Influenza A/H5N1 Vaccine|Drug: Placebo","UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States","https://ClinicalTrials.gov/show/NCT00133536"
60,"Comparative Study of Influenza Vaccines in Adults, FLUVACS-year 4","Completed","Has Results","Influenza","Biological: Fluzone|Biological: Flumist|Other: Physiologic saline","University of Michigan School of Public Heatlh, Ann Arbor, Michigan, United States|Western Michigan University Health Services, Kalamazoo, Michigan, United States|Central Michigan University Health Services, Mount Pleasant, Michigan, United States|Eastern Michigan University Health Services, Ypsilanti, Michigan, United States","https://ClinicalTrials.gov/show/NCT00538512"
61,"Study of the Safety and Immunogenicity of an Influenza Vaccine Administered to Healthy Adults","Completed","Has Results","Influenza Disease; Flu","Biological: Influenza Virus Vaccine","Bardstown, Kentucky, United States|Pittsburgh, Pennsylvania, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00264576"
62,"Alternative Oseltamivir Dosing Strategies","Completed","No Results Available","Influenza","Drug: Oseltamivir","VA Greater Los Angeles Healthcare System, Los Angeles, California, United States|VA Palo Alto Health Care System, Palo Alto, California, United States|National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Brooke Army Medical Center, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00334529"
63,"Safety and Immunogenicity of Fluzone® Vaccine in Children Who Received 2 Doses of the 2005-2006 Fluzone Formulation.","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine, Fluzone®","Layton, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00390884"
64,"Study to Evaluate the Immune Responses of Trivalent Cold-Adapted Influenza Vaccine (CAIV-T) Compared With (TIV)","Completed","No Results Available","Influenza","Biological: CAIV-T|Other: TIV","Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Alpine Pediatrics, Pleasant Grove, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|Families First Pediatrics, South Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00111579"
65,"Safety and Reactogenicity of FluBlok and Comparison of Immunogenicity, Efficacy and Effectiveness Against TIV","Completed","Has Results","Influenza","Biological: FluBlok Influenza Vaccination|Biological: TIV (Fluzone) Influenza Vaccination","Kaiser Permanente Pediatric Clinic - Fresno, Fresno, California, United States|Kaiser Permanente Pediatric Clinic - Hayward, Hayward, California, United States|Kaiser Permanente Pediatric Clinic - Roseville, Roseville, California, United States|Kaiser Permanente Pediatric Clinic - Sacramento, Sacramento, California, United States|Kaiser Permanente, Honolulu, Hawaii, United States","https://ClinicalTrials.gov/show/NCT00539864"
66,"Dose-Escalating Trial Using Vero Cell-culture Derived H5N1 +/- Aluminum in Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Vero cell based whole virus influenza A/H5N1|Drug: Placebo","Stanford University, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Maryland School of Medicine, Baltimore, Maryland, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00382980"
67,"Studies of Influenza Vaccine and Tetanus-Pneumococcal Vaccine in HIV-infected Patients Receiving Interleukin-2","Completed","No Results Available","HIV Infections","Drug: Interleukin-2","National Institutes of Health Clinical Center, 9000 Rockville Pike, Bethesda, Maryland, United States|Hvidovre University Hospital@@@Copenhagen, Denmark, Copenhagen, Denmark","https://ClinicalTrials.gov/show/NCT00050726"
68,"A/H5N1 Dose Ranging Study With Adjuvant Patch","Completed","No Results Available","Pandemic Influenza","Biological: A/H5N1|Biological: Placebo","Solano Clinical Research, Vallejo, California, United States|Miami Research Associates, Miami, Florida, United States|Quintiles Phase One Services, Kansas City, Kansas, United States|Jean Brown Research, Salt Lake City, Utah, United States|Northwest Kinetics, Tacoma, Washington, United States","https://ClinicalTrials.gov/show/NCT00532792"
69,"FLU-VACS Comparative Study in Adults","Completed","No Results Available","Influenza","Biological: Cold-adapted live attenuated influenza virus vaccine, trivalent|Other: Placebo|Biological: Trivalent inactivated influenza vaccine","Ann Arbor West, Ann Arbor, Michigan, United States|University of Michigan, Ann Arbor, Michigan, United States|Western Michigan University Health Services, Kalamazoo, Michigan, United States|Livonia East, Livonia, Michigan, United States|Central Michigan University Health Services, Mt. Pleasant, Michigan, United States|Eastern Michigan University Health Services, Ypsilanti, Michigan, United States","https://ClinicalTrials.gov/show/NCT00133523"
70,"Evaluation of Responses to Fluzone® in Infants ≥ 6 Months of Age Who Did or Did Not Receive Fluzone® at 2 Months of Age","Completed","Has Results","Influenza","Biological: Influenza Virus Vaccine","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00885105"
71,"A Study of Tamiflu (Oseltamivir) for Seasonal Prophylaxis of Influenza in Children.","Completed","No Results Available","Influenza","Drug: oseltamivir [Tamiflu]","West Palm Beach, Florida, United States|Pittsburgh, Pennsylvania, United States|Jackson, Tennessee, United States|El Paso, Texas, United States|Coquitlam, British Columbia, Canada|Aalborg, Denmark","https://ClinicalTrials.gov/show/NCT00412555"
72,"Safety and Immunogenicity Testing of Influenza Vaccine in Healthy Children 2 Months and 6 Months of Age","Completed","Has Results","Influenza","Biological: Influenza virus vaccine (2004-2005 Formulation)","Little Rock, Arkansas, United States|Marietta, Georgia, United States|Durham, North Carolina, United States|Akron, Ohio, United States|Dayton, Ohio, United States|Pittsburgh, Pennsylvania, United States|Norfolk, Virginia, United States|Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00858468"
73,"Pediatric Safety and Immunogenicity Study of Cell-Culture Derived and Egg-based Subunit Influenza Vaccines in Healthy Children and Adolescents","Completed","Has Results","Influenza","Biological: Cell culture-derived influenza subunit vaccine (cTIV)|Biological: Egg derived influenza subunit vaccine (eTIV)","Site 09, Fayetteville, Arkansas, United States|Site 10, Downey, California, United States|Site 02, Bardstown, Kentucky, United States|Site 14, Metairie, Louisiana, United States|Site 01, St. Louis, Missouri, United States|Site 11, Omaha, Nebraska, United States|Site 04, Edison, New Jersey, United States|Site 05, Endwell, New York, United States|Site 16, Fort Worth, Texas, United States|Site 13, San Angelo, Texas, United States|Site 12, San Antonio, Texas, United States|Site 08, Bountiful, Utah, United States|Site 07, Salt Lake City, Utah, United States|Site 03, Salt Lake City, Utah, United States|Site 06, Burke, Virginia, United States|Site 15, Spokane, Washington, United States|Site 44:Spec. Pediatric Dispensary, Dakovo, Croatia|Site 83, Ljudevita Gaja 2, Djakovo, Croatia|Site 43: Spec. Pediatric Dispensary, Sisak, Croatia|Site 27:Institute of Public Health, Zagreb, Croatia|Site 29: Institute of Public Health, Zagreb, Croatia|Site 40:Spec. Pediatric Dispensary, Zagreb, Croatia|Site 49: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 50: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 86: Spec. Pediatric Dispensary, Zagreb, Croatia|Site 70: Espoon rokotetutkimusklinikka, Heikintori, Espoo, Finland|Site 79: Kokkola Vaccine Research Clinic, Rantakatu 7, Kokkola, Finland|Site 78: Kuopio Vaccine Research Clinic, Microkatu 1,Osa/Section A, 3rd floor PL1188, Kuopio, Finland|Site 71: Etelä-Helsingin rokotetutkimusklinikka, Helsinki, Finland|Site 72: Itä-Helsingin rokotetutkimusklinikka, Helsinki, Finland|Site 76: Järvenpään rokotetutkimusklinikka, Järvenpää, Finland|Site 77: Kotkan rokotetutkimusklinikka, Kotka, Finland|Site 67: Lahden rokotetutkimusklinikka, Lahti, Finland|Site 75: Oulun rokotetutkimusklinikka, Oulu, Finland|Site 68: Porin rokotetutkimusklinikka, Pori, Finland|Site 66: Tampereen rokotetutkimusklinikka, Tampere, Finland|Site 69: Turun rokotetutkimusklinikka, Turku, Finland|Site 73: Itä-Vantaan rokotetutkimusklinikka, Vantaa, Finland|Site 74: Länsi-Vantaan rokotetutkimusklinikka, Vantaa, Finland|Site 57: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 53: Heim Pál Gyermekkórház, Budapest, Hungary|Site 52: Ferencvárosi Gyermekorvos Kft., Budapest, Hungary|Site 56: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 54: Házi Gyermekorvosi Rendelő, Budapest, Hungary|Site 51: 5053. számú Gyermekorvosi Rendelő, Miskolc, Hungary|Site 55: Revamed kft., Nyíregyháza, Hungary|Site 59: Vas Megyei Markusovszky Lajos, Általános, Rehabilitációs és Gyógyfürdő Kórház, Egyetemi Oktató Kórház, Szombathely, Hungary|Site 42: Dipartimento di Medicina Clinica e Sperimentale - Sezione di Igiene e Medicina Preventiva, Ferrara, Italy|Site 47: Dipartimento Scienze della Salute, Sezione di Igiene e Medicina Preventiva, Univesità di Genova, Genova, Italy|Site 41: Ospedale Maggiore della Carità-Clinica Pediatrica, Novara, Italy|Site 46: USL 2 Perugia, Distretto del perugino, Centro di Salute n. 4 (Madonna Alta) e n. 6 (Ellera di Corciano del distretto del perugino), Perugia, Italy|Site 45: AUSL 7, Ragusa, Italy|Site 35, Kaunas, Lithuania|Site 36, Vilnius, Lithuania|Site 32, Vilnius, Lithuania|Site 34, Vilnius, Lithuania|Site 31, Vilnius, Lithuania|Site 33, Vilnius, Lithuania|Site 25, Campulung Muscel, Arges, Romania|Site 21, Craiova, Dolj, Romania","https://ClinicalTrials.gov/show/NCT00645411"
74,"Evaluation of the Efficacy and Safety of Peramivir in Subjects With Uncomplicated Acute Influenza.","Completed","Has Results","Influenza","Drug: Peramivir 150 mg|Drug: Peramivir 300 mg|Drug: Placebo","Radiant Research, Birmingham, Alabama, United States|Clopton Clinic, Jonesboro, Arkansas, United States|Advanced Clinical Research Institute, Anaheim, California, United States|Orange County Clinical Trials, Anaheim, California, United States|Medical Center, Carmichael, California, United States|Pacific Sleep Medicines Service, El Centro, California, United States|Advanced Clinical Research Institute, Orange, California, United States|Benchmark Research, Sacramento, California, United States|Pacific Sleep Medicine Services, San Diego, California, United States|Pacific Sleep Medicine Services, San Francisco, California, United States|Alpine Clinical Research Center, Boulder, Colorado, United States|George Washington Unviersity, Washington, District of Columbia, United States|Clinical Research of Southern Florida, Coral Gables, Florida, United States|University Clinical Research-Deland, LLC, DeLand, Florida, United States|Florida Medical Research Institute, Gainesville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Clinical Research Center, Sarasota, Florida, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Georgia Clinical Research, Atlanta, Georgia, United States|Wishard Hospital, Indianapolis, Indiana, United States|Radiant Research, Overland Park, Kansas, United States|Kentucky Pediatric / Adult Research, Bardstown, Kentucky, United States|Central Kentucky Research Assoc, Inc, Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Radiant Research, Minneapolis, Edina, Minnesota, United States|Barnes-Jewish Hospital Emergency Department, St Louis, Missouri, United States|Medex Healthcare Research, Inc., St. Louis, Missouri, United States|Radiant Research, St. Louis, Missouri, United States|Bozeman Urgent Care Center, Bozeman, Montana, United States|Alliance Medical Center, Alliance, Nebraska, United States|Midwest Family Physicians, Omaha, Nebraska, United States|UMDNJ, Cherry Hill, New Jersey, United States|Pulmonary & Critical Care Associates, East Brunswick, New Jersey, United States|Brooklyn Hospital Center, Brooklyn, New York, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Summa Health, Akron, Ohio, United States|Sterling Research Group, LTD., Cincinnati, Ohio, United States|Integrated Medical Research, PC, Ashland, Oregon, United States|Research Across America at Oyster Point Family Health Center, Lancaster, Pennsylvania, United States|Radiant Research, Philadelphia, Pennsylvania, United States|Primary Physicians Research, Inc, Pittsburgh, Pennsylvania, United States|New England Center for Clinical Research, Inc, Cranston, Rhode Island, United States|Paragon Clinical Research, Inc., Cranston, Rhode Island, United States|Omega Medical Research, Warwick, Rhode Island, United States|Hillcrest Family Practice, Simpsonville, South Carolina, United States|Research Across America, Dallas, Texas, United States|Radiant Research, Dallas, Texas, United States|Towngate Plaza Medical Center, Garland, Texas, United States|Baylor Clinic-Baylor College of Medicine, Houston, Texas, United States|GSA Research, San Antonio, Texas, United States|Radiant Research-San Antonio Northeast, San Antonio, Texas, United States|Radiant Research San Antonio, San Antonio, Texas, United States|Balbir Chahal M.D. ,P.A, Tomball, Texas, United States|Dynamed Clinical Research, Tomball, Texas, United States|J. Lewis Research, Inc. Foothill Family Clinic, Salt Lake City, Utah, United States|J. Lewis Research, Inc. Foothill Family Clinic South, Salt Lake City, Utah, United States|J. Lewis Research, Inc./Southwest Family Medicine, West Jordan, Utah, United States|Calgary West Medical Cnetre Clinical Studies, Calgary, Alberta, Canada|Belvedere Medicentre, Edmonton, Alberta, Canada|Hermitage Medicentres, Edmonton, Alberta, Canada|RJA Medicentres, Edmonton, Alberta, Canada|Castledowns Medicentre, Edmonton, Alberta, Canada|Gain Medical Centre, Coquitlam, British Columbia, Canada|Source Unique Clinic, Hawkesbury, Ontario, Canada|Manna Research, Toronto, Ontario, Canada|Omnispec Clinical Reasearch Inc, Mirabel, Quebec, Canada|Clinique Medicale des Campus, Ste-Foy, Quebec, Canada|Prairie Clinical, Saskatoon, Saskatchewan, Canada","https://ClinicalTrials.gov/show/NCT00419263"
75,"Study on the Incidence of Influenza and Its Complications, in Subjects Aged 50 Years and Over Vaccinated With Fluarix™","Completed","Has Results","Influenza","Biological: Fluarix™","GSK Investigational Site, Mobile, Alabama, United States|GSK Investigational Site, Delray Beach, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Camillus, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Gueglingen, Baden-Wuerttemberg, Germany|GSK Investigational Site, Rudersberg, Baden-Wuerttemberg, Germany|GSK Investigational Site, Weinheim, Baden-Wuerttemberg, Germany|GSK Investigational Site, Potsdam, Brandenburg, Germany|GSK Investigational Site, Frankfurt/Main, Hessen, Germany|GSK Investigational Site, Essen, Nordrhein-Westfalen, Germany|GSK Investigational Site, Witten, Nordrhein-Westfalen, Germany|GSK Investigational Site, Mainz, Rheinland-Pfalz, Germany|GSK Investigational Site, Rhaunen, Rheinland-Pfalz, Germany|GSK Investigational Site, Magdeburg, Sachsen-Anhalt, Germany|GSK Investigational Site, Dresden, Sachsen, Germany|GSK Investigational Site, Leipzg, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Hamburg, Germany|GSK Investigational Site, Utrecht, Netherlands|GSK Investigational Site, Debica, Poland|GSK Investigational Site, Krakow, Poland|GSK Investigational Site, Mielec, Poland|GSK Investigational Site, Porabka, Poland|GSK Investigational Site, Siemianowice Slaskie, Poland|GSK Investigational Site, Wroclaw, Poland","https://ClinicalTrials.gov/show/NCT00377611"
76,"Evaluation of Efficacy and Safety of Peramivir in Adults With Acute Serious or Potentially Life-threatening Influenza","Completed","Has Results","Influenza","Drug: Peramivir 200 mg|Drug: Peramivir 400 mg|Drug: Oseltamivir","Pulmonary Associates of Mobile, P.C., Mobile, Alabama, United States|St. Bernards Research Center/Clopton Clinic, Jonesboro, Arkansas, United States|Pulmonary Consultants & Primary Care Physicians Medical Group, Inc., Orange, California, United States|University of California Irvine Medical Center, Orange, California, United States|University of California Davis Medical Center, Department of Emergency Medicine, Sacramento, California, United States|Good Samaritan Hospital, San Jose, California, United States|National Jewish Medical and Research Center, Clinical Research Unit, Denver, Colorado, United States|Orlando Regional Healthcare, Orlando, Florida, United States|James A. Haley Veterans Hospital, Department of Infectious Disease, Tampa, Florida, United States|Medical College of Georgia, Augusta, Georgia, United States|Infectious Disease Specialists of Atlanta, P.C., Decatur, Georgia, United States|St. Joseph's/Candler Health System, Inc., Savannah, Georgia, United States|Idaho Falls Infectious Diseases, PLLC, Idaho Falls, Idaho, United States|Northwestern University, Chicago, Illinois, United States|Springfield Clinic, LLP, Springfield, Illinois, United States|Wishard Hospital/Indiana University, Indianapolis, Indiana, United States|Infectious Disease of Indiana, PSC, Indianapolis, Indiana, United States|Natchitoches Internal Medicine, Natchitoches, Louisiana, United States|Louisiana State University Health Sciences Center-Shreveport, Shreveport, Louisiana, United States|VA Maryland Health Care System, Baltimore, Maryland, United States|Franklin Square Hospital, Baltimore, Maryland, United States|Beth Israel Deaconess Medical Center, Boston, Massachusetts, United States|Wayne State University School of Medicine, Detroit, Michigan, United States|Henry Ford Health System, Detroit, Michigan, United States|William Beaumont Hospital Troy, Troy, Michigan, United States|Washington University School of Medicine, St. Louis, Missouri, United States|Mercury Street Medical Group, PLLC, Butte, Montana, United States|Hackensack University Medical Center, Department of Infectious Disease, Hackensack, New Jersey, United States|Jersey Shore University Medical Center, Neptune, New Jersey, United States|University of New Mexico, Albuquerque, New Mexico, United States|Rochester General Hospital/University of Rochester, Rochester, New York, United States|University of Rochester Medical Center, Rochester, New York, United States|University Hospitals Case Medical Center, Cleveland, Ohio, United States|Temple University Hospital, Philadelphia, Pennsylvania, United States|Lowcountry Infectious Diseases, P.A., Charleston, South Carolina, United States|Baylor College of Medicine, Houston, Texas, United States|University of Utah Health Sciences Center, Salt Lake City, Utah, United States|Veterans Affairs Medical Center, Salem, Virginia, United States|Franciscan Health System, Tacoma, Washington, United States|Marshfield Clinic, Marshfield, Wisconsin, United States|Medical College of Wisconsin, Milwaukee, Wisconsin, United States|Prince Of Wales Hospital, Randwick, New South Wales, Australia|Westmead Hospital, Wentworthville, New South Wales, Australia|Cairns Base Hospital, Cairns, Queensland, Australia|Mater Adult Hospital, South Brisbane, Queensland, Australia|Gold Coast Hospital, Southport, Queensland, Australia|Princess Alexandra Hospital, Woolloongabba, Queensland, Australia|Repatriation General Hospital, Daw Park, South Australia, Australia|Royal Melbourne Hospital, Parkville, Victoria, Australia|Sir Charles Gairdner Hospital, Nedlands, Western Australia, Australia|Kelowna General Hospital, Kelowna, British Columbia, Canada|Hamilton Health Sciences-McMaster University Medical Centre, Hamilton, Ontario, Canada|St. Joseph's Healthcare Hamilton-L424, Hamilton, Ontario, Canada|The Ottawa Hospital - General Campus, Ottawa, Ontario, Canada|Mount Sinai Hospital / Toronto Medical Laboratories, Toronto, Ontario, Canada|Center de Sante et des Services Sociaux de Chicoutimi, Chicoutimi, Quebec, Canada|Maisonneuve-Rosemont Hospital, Montreal, Quebec, Canada|Centre de sante et de services sociaux Rimouski-Neigette (CSSSRN), Rimouski, Quebec, Canada|Division of Infectious Diseases, Saskatoon, Saskatchewan, Canada|Centre Hospitalier Universitaire de Quebec-Pavillon CHUL, Quebec, Canada|Princess Margaret Hospital, Hong Kong, Hong Kong|Queen Mary Hospital, Hong Kong, Hong Kong|United Christian Hospital, Hong Kong, Hong Kong|The Prince of Wales Hospital, Shatin - New Territories, Hong Kong|Christchurch Hospital, Christchurch, New Zealand|Waikato Hospital, Hamilton, New Zealand|Tauranga Hospital, Tauranga, New Zealand|National University Hospital, Singapore, Singapore|Tan Tock Seng Hospital, Singapore, Singapore|Global Clinical Trial Center, Port Elizabeth, E. Cape, South Africa|Genclin Corporation, Bloemfontein, Free State, South Africa|Benmed / Pentagon Hospital, Benoni, Gauteng, South Africa|Private Practice, Cape Town, Gauteng, South Africa|Newgate Centre, Johannesburg,, Gauteng, South Africa|DJW Navorsing, Krugersdorp, Gauteng, South Africa|Medforum Hospital, Pretoria, Gauteng, South Africa|Eugene Marais Hospital, Pretoria, Gauteng, South Africa|Global Clinical Trials (GCT), Pretoria, Gauteng, South Africa|Dr Bhorat, Soweto, Gauteng, South Africa|Sebastian, P, Durban, KZ-Natal, South Africa|Eksteen, MC, Nelspruit, Mpumalanga, South Africa|Dr. L.J. van Zyl, Worcester, W Cape, South Africa|N1 City Hospital, Cape town, WC, South Africa","https://ClinicalTrials.gov/show/NCT00453999"
77,"H5 Vaccine Alone or With Aluminum Hydroxide in Elderly Adults","Completed","No Results Available","Influenza","Biological: Aluminum hydroxide|Biological: Inactivated Influenza A/H5N1 Vaccine (sanofi pasteur)","University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University - Pediatric - Vanderbilt Vaccine Research Center, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00294099"
78,"Immunogenicity, Safety and Tolerability of CSL Limited Inactivated Influenza Vaccine in Adults","Completed","No Results Available","Influenza","Biological: CSL Trivalent Inactivated Influenza Vaccine - Thimerosal-free|Biological: CSL Trivalent Inactivated Influenza Vaccine with Thimerosal|Biological: Placebo with Thimerosal","Stanford University, Stanford, California, United States|University of Iowa, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester, Rochester, New York, United States|Duke University Medical Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States|Clinical Alliance for Research & Education - Infectious Diseases, Annandale, Virginia, United States","https://ClinicalTrials.gov/show/NCT00333398"
79,"Study to Evaluate the Safety and Immune Response of Two-Doses of Candidate Influenza Vaccine GSK 1557484A in Adults","Completed","Has Results","Influenza","Biological: Pumarix™|Biological: Pandemrix ™","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00510874"
80,"Evaluate Safety & Immunogenicity of GSK Bio's Influenza Vaccine GSK576389A After Repeated Vaccination in Elderly Adults","Completed","Has Results","Influenza","Biological: Fluarix|Biological: GSK Biologicals Influenza Vaccine GSK576389A","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Coral Gables, Florida, United States|GSK Investigational Site, Milford, Massachusetts, United States|GSK Investigational Site, Chaska, Minnesota, United States|GSK Investigational Site, Somers Point, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Gent, Belgium|GSK Investigational Site, Messkirch, Baden-Wuerttemberg, Germany|GSK Investigational Site, Augsburg, Bayern, Germany|GSK Investigational Site, Haag, Bayern, Germany|GSK Investigational Site, Hoehenkirchen-Siegertsbrunn, Bayern, Germany|GSK Investigational Site, Langquaid, Bayern, Germany|GSK Investigational Site, Ruedersdorf, Brandenburg, Germany|GSK Investigational Site, Leipzig, Sachsen, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Berlin, Germany|GSK Investigational Site, Bekkestua, Norway|GSK Investigational Site, Bergen, Norway|GSK Investigational Site, Elverum, Norway|GSK Investigational Site, Fredrikstad, Norway|GSK Investigational Site, Hamar, Norway|GSK Investigational Site, Haugesund, Norway|GSK Investigational Site, Skien, Norway","https://ClinicalTrials.gov/show/NCT00529516"
81,"Study Comparing the Immune Response and Safety of Fluarix and Fluzone Influenza Vaccines in Children","Completed","Has Results","Influenza","Biological: Fluarix™|Biological: Fluzone","GSK Investigational Site, Antioch, California, United States|GSK Investigational Site, Fairfield, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Pleasanton, California, United States|GSK Investigational Site, Redwood City, California, United States|GSK Investigational Site, Richmond, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, San Francisco, California, United States|GSK Investigational Site, Santa Clara, California, United States|GSK Investigational Site, Santa Rosa, California, United States|GSK Investigational Site, Vacaville, California, United States|GSK Investigational Site, Vallejo, California, United States|GSK Investigational Site, Walnut Creek, California, United States|GSK Investigational Site, Englewood, Colorado, United States|GSK Investigational Site, Lakewood, Colorado, United States|GSK Investigational Site, Tifton, Georgia, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, Whitehouse Station, New Jersey, United States|GSK Investigational Site, Fishkill, New York, United States|GSK Investigational Site, Hopewell Junction, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Cary, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Uniontown, Pennsylvania, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States","https://ClinicalTrials.gov/show/NCT00383123"
82,"Study Comparing the Immune Response of Fluarix and Fluzone Influenza Vaccines","Completed","No Results Available","Influenza","Biological: Influenza","GSK Investigational Site, Clearwater, Florida, United States|GSK Investigational Site, Evansville, Indiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, St. Louis, Missouri, United States|GSK Investigational Site, Buffalo, New York, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Cincinnati, Ohio, United States|GSK Investigational Site, Carnegie, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00197288"
83,"Efficacy Study of Two Influenza Vaccines and Placebo in Healthy Adult Subjects","Completed","Has Results","Influenza","Biological: Cell culture-derived influenza vaccine|Biological: Egg-derived influenza virus vaccine|Biological: Placebo","Site 14, Denver, Colorado, United States|Site 15, Pembroke Pines, Florida, United States|Site 17, South Miami, Florida, United States|Site 13, Lenexa, Kansas, United States|Site 2, Bardstown, Kentucky, United States|Site 1, Saint Louis, Missouri, United States|Site 4, Edison, New Jersey, United States|Site 10, Binghamton, New York, United States|Site 5, Endwell, New York, United States|Site 16, Winston-Salem, North Carolina, United States|Site 11, Warwick, Rhode Island, United States|Site 12, Anderson, South Carolina, United States|Site 9, Austin, Texas, United States|Site 8, Dallas, Texas, United States|Site 7, Salt Lake City, Utah, United States|Site 3, Salt Lake City, Utah, United States|Site 6, Burke, Virginia, United States|Site 25, Espoo, Finland|Site 26, Helsinki, Finland|Site 27, Helsinki, Finland|Site 33, Järvenpää, Finland|Site 35, Kokkola, Finland|Site 34, Kotka, Finland|Site 30, Kuopio, Finland|Site 22, Lahti, Finland|Site 31, Oulu, Finland|Site 23, Pori, Finland|Site 32, Seinäjoki, Finland|Site 21, Tampere, Finland|Site 24, Turku, Finland|Site 28, Vantaa, Finland|Site 29, Vantaa, Finland|Site 49, Bydgoszcz, Poland|Site 53, Gniewkowo, Poland|Site 59, Katowice, Poland|Site 63, Kielce, Poland|Site 62, Końskie, Poland|Site 57, Krakow, Poland|Site 41, Kraków, Poland|Site 43, Kraków, Poland|Site 42, Kraków, Poland|Site 50, Kraków, Poland|Site 44, Lubartów, Poland|Site 45, Lublin, Poland|Site 65, Oleśnica, Poland|Site 47, Olsztyn, Poland|Site 48, Olsztyn, Poland|Site 46, Olsztyn, Poland|Site 58, Radziszów, Poland|Site 61, Ruda Śląska, Poland|Site 60, Rzeszów, Poland|Site 52, Warszawa, Poland|Site 55, Wilkowice, Poland|Site 64, Wrocław, Poland|Site 54, Wąbrzeźno, Poland|Site 51, Łodź, Poland","https://ClinicalTrials.gov/show/NCT00630331"
84,"Comparison of Delivery Routes of Flu Vaccine in Adults","Completed","No Results Available","Influenza","Biological: Trivalent inactivated influenza vaccine","Stanford University School of Medicine, Stanford, California, United States|UCLA Center For Vaccine Research, Torrance, California, United States|University of Iowa - Vaccine Research & Education Unit, Iowa City, Iowa, United States|University of Maryland Baltimore, Baltimore, Maryland, United States|Saint Louis University, St. Louis, Missouri, United States|University of Rochester Medical Center - Strong Memorial Hospital - Infectious Diseases, Rochester, New York, United States|Duke Health Center, Durham, North Carolina, United States|Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States|Vanderbilt University, Nashville, Tennessee, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00170547"
85,"Immunogenicity and Safety Study of an Inactivated Influenza Vaccine (Split Virus, Vero Cell Derived) in Adults Aged 50 Years and Older","Completed","No Results Available","Influenza","Biological: Vero cell derived, trivalent, seasonal influenza vaccine|Biological: Licensed egg-derived, trivalent seasonal influenza vaccine","Coastal Clinical Research, Inc., Mobile, Alabama, United States|Quality of Life Medical & Research Center, LLC, Tucson, Arizona, United States|Benchmark Research, San Francisco, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Clinical Research of South Florida, Coral Cables, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|University Clinical Research, Inc., Pembrook Pines, Florida, United States|Clinical Research Atlanta, Stockbridge, Georgia, United States|Johnson County Clin-Trials, Lenexa, Kansas, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Heartland Research Associates, LLC, Wichita, Kansas, United States|Heartland Research Associates LLC, Wichita, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Radiant Research, Inc., St. Louis, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Clinical Research Inc., Rochester, New York, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Omega Medical Research, Warwick, Rhode Island, United States|Palmetto Medical Research, Mt. Pleasant, South Carolina, United States|Clinical Research Associates, Inc. - Nashville, Nashville, Tennessee, United States|Benchmark Research Austin, Austin, Texas, United States|Benchmark Research Ft. Worth, Fort Worth, Texas, United States|Research Across America, Plano, Texas, United States|Benchmark Research San Angelo, San Angelo, Texas, United States|Pi-Coor Clinical Research, Fairfax, Virginia, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00782431"
86,"Efficacy Study of an Investigational Influenza Vaccine (Vero Cell Derived) to Prevent Culture Confirmed Influenza Infection (CCII)","Completed","No Results Available","Influenza","Biological: Inactivated seasonal influenza vaccine (split virus, Vero cell-derived)|Biological: Phosphate buffered saline","Radiant Research Tucson, Tuscon, Arizona, United States|Advanced Clinical Research Institute, Anaheim, California, United States|Orange County Clinical Research, Inc., Cypress, California, United States|Benchmark Research, Sacramento, California, United States|California Research Foundation, San Diego, California, United States|Benchmark Research San Francisco, San Francisco, California, United States|Tampa Bay Medical Research, Clearwater, Florida, United States|Jacksonville Center for Clinical Research, Jacksonville, Florida, United States|Miami Research Associates, Miami, Florida, United States|University Clinical Research, Inc., Pembroke, Florida, United States|Radiant Research Inc. - Chicago, Chicago, Illinois, United States|PRA International Clinical Pharmacology Center, Lenexa, Kansas, United States|Vince and Associates Clinical Research, Overland Park, Kansas, United States|Central Kentucky Research Associates, Inc., Lexington, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Columbia Medical Practice, Columbia, Maryland, United States|Center for Pharmaceutical Research, Kansas City, Missouri, United States|Sundance Clinical Research, St. Louis, Missouri, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Clinical Research Center of Nevada, Las Vegas, Nevada, United States|Rochester Clinical Research, Rochester, New York, United States|Metrolina Medical Research, Charlotte, North Carolina, United States|Wake Research Associates, LLC, Raleigh, North Carolina, United States|Piedmont Medical Research Associates, Winston-Salem, North Carolina, United States|Coastal Carolina Research Center, Goose Creek, South Carolina, United States|Spartanburg Medical Research, Spartanburg, South Carolina, United States|Clinical Research Associates, Inc. - Nashville, Nashville, Tennessee, United States|Benchmark Research Austin, Austin, Texas, United States|Research Across America - CNS Research Group, Dallas, Texas, United States|Benchmark Research Ft. Worth, Ft. Worth, Texas, United States|Research Across America - CNS Research Group, Plano, Texas, United States|Benchmark Research San Angelo, San Angelo, Texas, United States|Radiant Research - San Antonio Northeast, San Antonio, Texas, United States|Jean Brown Associates, Inc., Salt Lake City, Utah, United States|Clinical Research Associates of Tidewater, Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00566345"
87,"A Study of Oseltamivir (Tamiflu) for the Seasonal Prophylaxis of Influenza in Immunocompromised Participants","Completed","Has Results","Influenza","Drug: Oseltamivir|Drug: Placebo","Birmingham, Alabama, United States|Little Rock, Arkansas, United States|Stanford, California, United States|Denver, Colorado, United States|Hartford, Connecticut, United States|Newark, Delaware, United States|St Petersburg, Florida, United States|Atlanta, Georgia, United States|Augusta, Georgia, United States|Chicago, Illinois, United States|Chicago, Illinois, United States|New Orleans, Louisiana, United States|Detroit, Michigan, United States|Detroit, Michigan, United States|Brooklyn Center, Minnesota, United States|Missoula, Montana, United States|Camden, New Jersey, United States|Hackensack, New Jersey, United States|Livingston, New Jersey, United States|Newark, New Jersey, United States|Buffalo, New York, United States|New York, New York, United States|New York, New York, United States|Chapel Hill, North Carolina, United States|Charlotte, North Carolina, United States|Durham, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Oklahoma City, Oklahoma, United States|Hershey, Pennsylvania, United States|Philadelphia, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Dallas, Texas, United States|Houston, Texas, United States|Aalst, Belgium|Bruxelles, Belgium|Bruxelles, Belgium|Edegem, Belgium|Leuven, Belgium|Edmonton, Alberta, Canada|Coquitlam, British Columbia, Canada|Winnipeg, Manitoba, Canada|London, Ontario, Canada|Saskatoon, Saskatchewan, Canada|Brno, Czech Republic|Tallinn, Estonia|Tartu, Estonia|Paris, France|Paris, France|Paris, France|Toulouse, France|Tours, France|Aachen, Germany|Berlin, Germany|Hamburg, Germany|Heidelberg, Germany|München, Germany|München, Germany|Budapest, Hungary|Pecs, Hungary|Szeged, Hungary|Jerusalem, Israel|Petach Tikva, Israel|Ramat Gan, Israel|Padova, Italy|Pavia, Italy|Roma, Italy|Kaunas, Lithuania|Vilnius, Lithuania|Bialystok, Poland|Lodz, Poland|Szczecin, Poland|Warszawa, Poland|Warszawa, Poland|Madrid, Spain|Madrid, Spain|Birmingham, United Kingdom|Edinburgh, United Kingdom","https://ClinicalTrials.gov/show/NCT00412737"
88,"A Phase 2 Study to Evaluate Immune Responses of FluMist®","Completed","Has Results","Influenza Vaccine","Biological: TIV, Trivalent Inactivated Influenza Virus Vaccine|Biological: FluMist, Influenza Virus Vaccine Live","Harvey Pediatrics, Jonesboro, Arkansas, United States|Arkansas Pediatric Clinic, Little Rock, Arkansas, United States|NuLife Clinical Research, Anaheim, California, United States|Palm Beach Research Center, West Palm Beach, Florida, United States|Central Kentucky Research Associates, Lexington, Kentucky, United States|Peak Medical Research, LLC, Owensboro, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Meridian Clinical Research, LLC, Omaha, Nebraska, United States|Henderson Pediatrics, Henderson, Nevada, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Dayton Clinical Research, Dayton, Ohio, United States|Northeast Cincinnati Pediatric Asso., Inc., Mason, Ohio, United States|Celia Reyes-Acuna, M.D., Corpus Christi, Texas, United States|Allergy Immunology Research Center of North Texas, Dallas, Texas, United States|Healthcare Discoveries, Inc., San Antonio, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Bear Care Pediatrics, Ogden, Utah, United States|Advanced Pediatrics, Vienna, Virginia, United States|Pediatrics at the Beach, Virginia Beach, Virginia, United States","https://ClinicalTrials.gov/show/NCT00461981"
89,"Immunogenicity, Safety, Reactogenicity, Efficacy, Effectiveness and Lot Consistency of FluBlok","Completed","No Results Available","Influenza","Biological: Influenza Vaccine, recombinant hemagglutinin, FluBlok","Impact Clinical Trials, Beverly Hills, California, United States|Benchmark Research - Sacramento, Sacramento, California, United States|Benchmark Research - San Francisco, San Francisco, California, United States|University Clinical Research, Inc, Pembroke Pines, Florida, United States|Vince and Associates, Overland Park, Kansas, United States|Kentucky pediatric /Adult Research, Bardstown, Kentucky, United States|Benchmarch Research - New Orleans, Metairie, Louisiana, United States|University of Maryland - Baltimore, Baltimore, Maryland, United States|Saint Louis University, Saint Louis, Missouri, United States|Meridian Clinical Research, Omaha, Nebraska, United States|Regional Clinical Research, Inc., Endwell, New York, United States|Rochester Medical Center, Rochester, New York, United States|Carolina Medical Trials, Winston-Salem, North Carolina, United States|Sterling Research, Cincinnati, Ohio, United States|Primary Physicians Research - Pediatric Alliance St. Clair, Pittsburgh, Pennsylvania, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States|Vanderbilt University Medical Center, Nashville, Tennessee, United States|Benchmarch Research - Austin, Austin, Texas, United States|Benchmark Research - Fort Worth, Fort Worth, Texas, United States|Baylor College of Medicine, Houston, Texas, United States|Benchmark Research - San Angelo, San Angelo, Texas, United States|Jean Brown Research, Salt Lake City, Utah, United States|University of Virginia Health System, Charlottesville, Virginia, United States|Marshfield Clinic, Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00539981"
90,"Study of Inactivated, Split-Virion Influenza Vaccine and Standard Fluzone® Vaccine in Adult and Elderly Subjects","Completed","Has Results","Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 1)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (Intradermal Formulation 2)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (Standard dose)|Biological: Split, Inactivated, Trivalent Influenza Vaccine (High-dose)","Alabaster, Alabama, United States|Mobile, Alabama, United States|Chandler, Arizona, United States|Mesa, Arizona, United States|Phoenix, Arizona, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|San Diego, California, United States|Stanford, Connecticut, United States|Pembroke Pines, Florida, United States|Pinellas Park, Florida, United States|Boise, Idaho, United States|Chicago, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|St. Louis, Missouri, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Allentown, Pennsylvania, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Goose Creek, South Carolina, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Salt Lake City, Utah, United States|West Jordan, Utah, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00551031"
91,"Comparison of the Immunogenicity, Safety and Reactogenicity of FluBlok, To a Licensed Vaccine In Elderly Adults","Completed","No Results Available","Influenza","Biological: Influenza Vaccination","Center of Vaccine Development, Univ. of Maryland, Baltimore, Maryland, United States|Passport Health Maryland, Baltimore, Maryland, United States|Mayo Clinic College of Medicine, Rochester, Minnesota, United States|Passport Health New Jersey, Shrewsbury, New Jersey, United States|Rochester Medical Center, Rochester, New York, United States|Primary Physicians Research, Pittsburg, Pennsylvania, United States|Baylor College of Medicine, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00395174"
92,"Immunogenicity & Safety of GSK's Influenza Vaccine 1557484A Given to Adults Aged ≥18 Years","Completed","Has Results","Influenza","Biological: Influenza A (H5N1) Virus Monovalent Vaccine, Adjuvanted|Biological: Placebo","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Anaheim, California, United States|GSK Investigational Site, Jacksonville, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Miami, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Stockbridge, Georgia, United States|GSK Investigational Site, Chicago, Illinois, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, South Bend, Indiana, United States|GSK Investigational Site, Lenexa, Kansas, United States|GSK Investigational Site, Wichita, Kansas, United States|GSK Investigational Site, Metairie, Louisiana, United States|GSK Investigational Site, Rockville, Maryland, United States|GSK Investigational Site, Saint Louis, Missouri, United States|GSK Investigational Site, Missoula, Montana, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Edison, New Jersey, United States|GSK Investigational Site, Poughkeepsie, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Spartanburg, South Carolina, United States|GSK Investigational Site, Nashville, Tennessee, United States|GSK Investigational Site, Austin, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, San Angelo, Texas, United States|GSK Investigational Site, Halifax, Nova Scotia, Canada|GSK Investigational Site, Truro, Nova Scotia, Canada|GSK Investigational Site, London, Ontario, Canada|GSK Investigational Site, Sarnia, Ontario, Canada|GSK Investigational Site, Sudbury, Ontario, Canada|GSK Investigational Site, Woodstock, Ontario, Canada|GSK Investigational Site, Pointe-Claire, Quebec, Canada|GSK Investigational Site, Quebec City, Quebec, Canada|GSK Investigational Site, Sherbrooke, Quebec, Canada|GSK Investigational Site, St-Romuald, Quebec, Canada","https://ClinicalTrials.gov/show/NCT00616928"
93,"Immunogenicity of a Split, Cell-Based, Inactivated, Trivalent Influenza Vaccine in Healthy Adult Subjects","Completed","Has Results","Influenza|Orthomyxoviruses|Myxovirus Infection","Biological: Influenza virus vaccine - cell based (2007-2008 Formulation)|Biological: Influenza virus vaccine - cell-based (2007-2008 Formulation)|Biological: Influenza virus vaccine (2007-2008 Formulation)","Hoover, Alabama, United States|Mobile, Alabama, United States|Tucson, Arizona, United States|Milford, Connecticut, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Wichita, Kansas, United States|Kansas City, Missouri, United States|Springfield, Missouri, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Cincinnati, Ohio, United States|Bensalem, Pennsylvania, United States|Warwick, Rhode Island, United States|Mt Pleasant, South Carolina, United States","https://ClinicalTrials.gov/show/NCT00845429"
94,"Safety Study to Evaluate FluMist in Immunocompromised Children","Completed","Has Results","Cancer","Biological: FluMist|Biological: Placebo","University of Rochester School of Medicine & Dentistry, Rochester, New York, United States|Stony Brook University Medical Center, Stony Brook, New York, United States|St. Jude's Children's Research Hospital, Memphis, Tennessee, United States|Vanderbilt University, Nashville, Tennessee, United States|Children's Hospital Regional Medical Center, Seattle, Washington, United States","https://ClinicalTrials.gov/show/NCT00112112"
95,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Elderly Subjects","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine","Alabaster, Alabama, United States|Tucson, Arizona, United States|Fountain Valley, California, United States|Pinellas Park, Florida, United States|Chicago, Illinois, United States|Springfield, Missouri, United States|Brooklyn, New York, United States|New York, New York, United States|Bensalem, Pennsylvania, United States|Grove City, Pennsylvania, United States|Johnstown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Fort Worth, Texas, United States|Galveston, Texas, United States|Layton, Utah, United States|South Jordan, Utah, United States|Norfolk, Virginia, United States","https://ClinicalTrials.gov/show/NCT00388583"
96,"Trial to Assess the Shedding,Immunogenicity, and Safety of FluMist Administered to Healthy Individuals 5-49 Years of Age","Completed","No Results Available","Influenza","Biological: FluMist","SFBC International, Inc, Miami, Florida, United States|Children's Memorial Hospital, Chicago, Illinois, United States|Kentucky Pediatric / Adult Research, Inc, Bardstown, Kentucky, United States|University of Maryland, School of Medicine, Baltimore, Maryland, United States|Center for Vaccine Development, Saint Louis, Missouri, United States|Creighton University Medical Center, Omaha, Nebraska, United States|Pediatric Clinical Trials International, Columbus, Ohio, United States|Primary Physician's Research Inc., Pittsburgh, Pennsylvania, United States|Vanderbilt University Medical Center North, Nashville, Tennessee, United States|University of Virginia, Elson Student Health Center, Charlottesville, Virginia, United States|Marshall University Medical Center, Huntington, West Virginia, United States","https://ClinicalTrials.gov/show/NCT00192140"
97,"Study of Inactivated, Split-Virion Influenza Vaccine Compared With Standard Fluzone Vaccine in Infants and Children","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: Split, Inactivated, Trivalent Influenza Vaccine|Biological: Split, Inactivated, Trivalent Influenza Vaccine ( Fluzone® 2006/2007 Formulation)","Harrisburg, Arkansas, United States|Little Rock, Arkansas, United States|Trumann, Arkansas, United States|Bellflower, California, United States|Downey, California, United States|Fountain Valley, California, United States|Paramount, California, United States|Owensboro, Kentucky, United States|Bossier City, Louisiana, United States|Shreveport, Louisiana, United States|Brainerd, Minnesota, United States|Cleveland, Ohio, United States|Erie, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Uniontown, Pennsylvania, United States|Wexford, Pennsylvania, United States|Fort Worth, Texas, United States|Salt Lake City, Utah, United States|Salt Lake City, Utah, United States","https://ClinicalTrials.gov/show/NCT00391391"
98,"Immunogenicity of High-dose Inactivated, Split-virion Influenza Vaccine Versus Standard Fluzone Vaccine in the Elderly","Completed","Has Results","Orthomyxoviridae Infection|Influenza|Myxovirus Infection","Biological: High-Dose Inactivated, Split-Virion Influenza Vaccine|Biological: Inactivated, Split-Virion Influenza Vaccine","Mesa, Arizona, United States|Phoenix, Arizona, United States|Tempe, Arizona, United States|Tucson, Arizona, United States|San Diego, California, United States|Stratford, Connecticut, United States|Clearwater, Florida, United States|Coral Gables, Florida, United States|Orlando, Florida, United States|Pembroke Pines, Florida, United States|Wichita, Kansas, United States|Rockville, Maryland, United States|Rochester, Minnesota, United States|Kansas City, Missouri, United States|St. Louis, Missouri, United States|Endwell, New York, United States|Rochester, New York, United States|Cary, North Carolina, United States|Raleigh, North Carolina, United States|Downington, Pennsylvania, United States|Erie, Pennsylvania, United States|Warwick, Rhode Island, United States|Dallas, Texas, United States|Plano, Texas, United States|West Jordan, Utah, United States|Norfolk, Virginia, United States|Richmond, Virginia, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00391053"
99,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 2, 4, 6 and 12 to 15 Months of Age","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined 792014|Biological: ActHIB|Biological: Pediarix/Infanrix Penta","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Hot Springs, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Madera, California, United States|GSK Investigational Site, Slinas, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Plantation, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Oaklawn, Illinois, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, West Desmoines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Nies, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Clyde, North Carolina, United States|GSK Investigational Site, Deerfield, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Akron, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, North Canton, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States|GSK Investigational Site, Katy, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Ogden, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Pleasant Gorve, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00345579"
100,"Safety and Immunogenicity Study of Hib-MenCY-TT Vaccine Compared to Licensed Hib Conjugate Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis 792014 vaccine|Biological: ActHIB|Biological: PedvaxHIB|Biological: Pediarix|Biological: Prevnar|Biological: M-M-R II|Biological: Varivax","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Bryant, Arkansas, United States|GSK Investigational Site, Fayetteville, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, East Artesia, California, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, La Jolla, California, United States|GSK Investigational Site, Oakland, California, United States|GSK Investigational Site, Paramount, California, United States|GSK Investigational Site, Rolling Hills Estates, California, United States|GSK Investigational Site, Sacramento, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Cocoa Beach, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Rockledge, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Arkansas City, Kansas, United States|GSK Investigational Site, Kansas City, Kansas, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Baltimore, Maryland, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Jamaica Plain, Massachusetts, United States|GSK Investigational Site, Kalamazoo, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, Brainerd, Minnesota, United States|GSK Investigational Site, Saint Paul, Minnesota, United States|GSK Investigational Site, Omaha, Nebraska, United States|GSK Investigational Site, North Las Vegas, Nevada, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Ithaca, New York, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Stony Brook, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Durham, North Carolina, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Sylva, North Carolina, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Columbus, Ohio, United States|GSK Investigational Site, Huber Heights, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Tulsa, Oklahoma, United States|GSK Investigational Site, Gresham, Oregon, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Hershey, Pennsylvania, United States|GSK Investigational Site, Philadelphia, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Sellersville, Pennsylvania, United States|GSK Investigational Site, Providence, Rhode Island, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Lexington, South Carolina, United States|GSK Investigational Site, Amarillo, Texas, United States|GSK Investigational Site, Fort Worth, Texas, United States|GSK Investigational Site, Galveston, Texas, United States|GSK Investigational Site, San Antonio, Texas, United States|GSK Investigational Site, Temple, Texas, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Pleasant Grove, Utah, United States|GSK Investigational Site, Saint George, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, Mechanicsville, Virginia, United States|GSK Investigational Site, Norfolk, Virginia, United States|GSK Investigational Site, Vancouver, Washington, United States|GSK Investigational Site, La Crosse, Wisconsin, United States|GSK Investigational Site, Randwick, New South Wales, Australia|GSK Investigational Site, Herston, Queensland, Australia|GSK Investigational Site, South Brisbane, Queensland, Australia|GSK Investigational Site, Carlton, Victoria, Australia|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00289783"
101,"Immunogenicity, Safety of GSKs Tdap Vaccine Boostrix When Coadministered With GSKs Influenza Vaccine Fluarix in Adults","Completed","Has Results","Acellular Pertussis|Diphtheria|Tetanus","Biological: Fluarix®|Biological: Boostrix®","GSK Investigational Site, Huntsville, Alabama, United States|GSK Investigational Site, Chandler, Arizona, United States|GSK Investigational Site, Mesa, Arizona, United States|GSK Investigational Site, Phoenix, Arizona, United States|GSK Investigational Site, Inverness, Florida, United States|GSK Investigational Site, Melbourne, Florida, United States|GSK Investigational Site, Pembroke Pines, Florida, United States|GSK Investigational Site, Peoria, Illinois, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Bristol, Tennessee, United States|GSK Investigational Site, Houston, Texas, United States","https://ClinicalTrials.gov/show/NCT00385255"
102,"Safety of Hib-MenCY-TT Vaccine Versus Licensed Hib Conjugate Vaccine, Given at 12 to 15 Months of Age.","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenzae type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine combined (792014)|Biological: PedvaxHIB|Biological: Prevnar|Biological: M-M-R II|Biological: Varivax","GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Birmingham, Alabama, United States|GSK Investigational Site, Benton, Arkansas, United States|GSK Investigational Site, Jonesboro, Arkansas, United States|GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Fresno, California, United States|GSK Investigational Site, Madera, California, United States|GSK Investigational Site, Slinas, California, United States|GSK Investigational Site, West Covina, California, United States|GSK Investigational Site, Boulder, Colorado, United States|GSK Investigational Site, Longmont, Colorado, United States|GSK Investigational Site, Plantation, Florida, United States|GSK Investigational Site, Nampa, Idaho, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, West Desmoines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Lexington, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Nies, Michigan, United States|GSK Investigational Site, Portage, Michigan, United States|GSK Investigational Site, Stevensville, Michigan, United States|GSK Investigational Site, St. Paul, Minnesota, United States|GSK Investigational Site, Las Vegas, Nevada, United States|GSK Investigational Site, Ithaca, New York, United States|GSK Investigational Site, New Hartford, New York, United States|GSK Investigational Site, Syracuse, New York, United States|GSK Investigational Site, Raleigh, North Carolina, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Canton, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, North Canton, Ohio, United States|GSK Investigational Site, South Euclid, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Wexford, Pennsylvania, United States|GSK Investigational Site, Charleston, South Carolina, United States|GSK Investigational Site, Kingsport, Tennessee, United States|GSK Investigational Site, Layton, Utah, United States|GSK Investigational Site, Ogden, Utah, United States|GSK Investigational Site, Orem, Utah, United States|GSK Investigational Site, Pleasant Gorve, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, Salt Lake City, Utah, United States|GSK Investigational Site, South Jordan, Utah, United States|GSK Investigational Site, West Jordan, Utah, United States|GSK Investigational Site, Madison, Wisconsin, United States|GSK Investigational Site, Marshfield, Wisconsin, United States|GSK Investigational Site, Mexico city, Mexico|GSK Investigational Site, Mexico, D.F., Mexico","https://ClinicalTrials.gov/show/NCT00345683"
103,"Long-Term Antibody Persistence at 1, 3 and 5 Years After a Fourth Dose of GSK Biologicals' Hib-MenCY-TT Vaccine Compared to ActHIB","Completed","Has Results","Neisseria Meningitidis|Haemophilus Influenzae Type b","Biological: MenHibrix (Hib-MenCY-TT)|Biological: Hib conjugate vaccine (ActHIB)","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Woodstock, Georgia, United States|GSK Investigational Site, Waukee, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Fall River, Massachusetts, United States|GSK Investigational Site, Pittsford, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, Cleveland, Ohio, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States","https://ClinicalTrials.gov/show/NCT00359983"
104,"Comparison of GSKBiologicals' Hib-MenCY-TT Vaccine vs Licensed Hib Conjugate or Meningococcal Vaccine","Completed","Has Results","Haemophilus Influenzae Type b|Neisseria Meningitidis","Biological: GSK Biologicals' Haemophilus influenza type b and Neisseria meningitidis serogroups C and Y-tetanus toxoid conjugate vaccine 792014 vaccine|Biological: ActHIB|Biological: Pediarix|Biological: Prevnar|Biological: Menomune","GSK Investigational Site, Little Rock, Arkansas, United States|GSK Investigational Site, Fountain Valley, California, United States|GSK Investigational Site, Centennial, Colorado, United States|GSK Investigational Site, Norwich, Connecticut, United States|GSK Investigational Site, Marietta, Georgia, United States|GSK Investigational Site, Des Moines, Iowa, United States|GSK Investigational Site, Bardstown, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Louisville, Kentucky, United States|GSK Investigational Site, Bossier City, Louisiana, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, Boston, Massachusetts, United States|GSK Investigational Site, New Bedford, Massachusetts, United States|GSK Investigational Site, Bronx, New York, United States|GSK Investigational Site, Rochester, New York, United States|GSK Investigational Site, Boardman, Ohio, United States|GSK Investigational Site, University Heights, Ohio, United States|GSK Investigational Site, Beaver Falls, Pennsylvania, United States|GSK Investigational Site, Erie, Pennsylvania, United States|GSK Investigational Site, Greenville, Pennsylvania, United States|GSK Investigational Site, Norristown, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Pittsburgh, Pennsylvania, United States|GSK Investigational Site, Rydal, Pennsylvania, United States|GSK Investigational Site, Warwick, Rhode Island, United States","https://ClinicalTrials.gov/show/NCT00129129"
105,"A Study to Evaluate the Shedding and Safety of Trivalent Influenza Virus Vaccine Live, Intranasal in Infants and Young Children","Completed","Has Results","Healthy","Biological: Trivalent influenza virus vaccine live, intranasal","Little Rock Allergy & Asthma Clinic, PA, Little Rock, Arkansas, United States|Pediatric and Adolescent Medicine, PA (PAMPA), Marietta, Georgia, United States|Kentucky Pediatrics/Adult Research, Bardstown, Kentucky, United States|Benchmark Research, Metairie, Louisiana, United States|Health Sciences Research Center, Cortland, New York, United States|Health Sciences Research Center, Elmira, New York, United States|Regional Clinical Research Inc., Endwell, New York, United States|Grand Prairie Pediatrics & Allergy Clinic, Oklahoma City, Oklahoma, United States|Primary Physicians Research , Inc, Pittsburgh, Pennsylvania, United States|Med-Pro Research Inc., Houston, Texas, United States|Central Texas Health Research, New Braunfels, Texas, United States|Benchmark Research, San Angelo, Texas, United States|Wee Care Pediatrics, Layton, Utah, United States|Utah Valley Pediatrics, Provo, Utah, United States|PI-Coor Clinical Research, LLC, Burke, Virginia, United States|Advanced Pediatrics, Vienna, Virginia, United States","https://ClinicalTrials.gov/show/NCT00344305"
106,"Study of the Safety, Immunogenicity and Lot Comparability of DAPTACEL When Administered With Other Recommended Vaccine","Completed","No Results Available","Diphtheria|Tetanus|Whooping Cough|Polio|Haemophilus Influenzae Type b","Biological: DAPTACEL® (Diphtheria and Tetanus Toxoids and Acellular Pertussis vaccine)|Biological: Pentacel: DTaP-IPV/Hib","Fayetteville, AR 72703, Arkansas, United States|Jonesboro, AR 72401, Arkansas, United States|Little Rock, AR 72211, Arkansas, United States|Fountain Valley, CA 92708, California, United States|Englewood, CO 80112, Colorado, United States|Norwich, CT 06360, Connecticut, United States|Orlando, FL 32856, Florida, United States|Marietta, GA 30062, Georgia, United States|Chicago, IL 60614, Illinois, United States|Bardstown, KY 40004, Kentucky, United States|Bossier City, LA 71111, Louisiana, United States|Bridgeton, MO 63044, Missouri, United States|Rochester, NY 14620, New York, United States|Chapel Hill, NC 27514, North Carolina, United States|Portland, OR 97201, Oregon, United States|Norristown, PA 19401, Pennsylvania, United States|Pittsburgh, PA 15213, Pennsylvania, United States|Pittsburgh, PA 15241, Pennsylvania, United States|Kingsport, TN 37664, Tennessee, United States|Austin, TX 78758, Texas, United States|Fort Worth, TX 76107, Texas, United States|San Antonio, TX 78205, Texas, United States|Provo, UT 84604, Utah, United States|Spokane, WA 99220, Washington, United States|LaCrosse, WI 54601, Wisconsin, United States|Marshfield, WI 54449, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00662870"
107,"Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™","Completed","Has Results","Diphtheria|Tetanus|Haemophilus Infection|Pertussis|Polio","Biological: Pentacel™: HCPDT-IPV//PRP-T Vaccine and Prevnar®","Montgomery, Alabama, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Fountain Valley, California, United States|Oakland, California, United States|Rolling Hills Estate, California, United States|Norwich, Connecticut, United States|Bardstown, Kentucky, United States|Louisville, Kentucky, United States|Boston, Massachusetts, United States|Kansas City, Missouri, United States|Brooklyn, New York, United States|Norristown, Pennsylvania, United States|Pittsburgh, Pennsylvania, United States|Austin, Texas, United States|Fort Worth, Texas, United States|San Antonio, Texas, United States|San Antonio, Texas, United States|Layton, Utah, United States|Spokane, Washington, United States|Vancouver, Washington, United States|Lacrosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00772928"
108,"Study of DAPTACEL® Administered as a 5th Dose in 4 to 6-Year-Old Children Previously Immunized With PENTACEL™","Completed","Has Results","Diphtheria|Tetanus|Pertussis|Polio|Haemophilus Infection","Biological: Diphtheria and Tetanus Toxoids and Acellular Pertussis (DAPTACEL®)","Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Oakland, California, United States|Torrance, California, United States|Orlando, Florida, United States|Atlanta, Georgia, United States|Boston, Massachusetts, United States|Woburn, Massachusetts, United States|Omaha, Nebraska, United States|Albany, New York, United States|Rochester, New York, United States|Chapel Hill, North Carolina, United States|Sylva, North Carolina, United States|Pittsburgh, Pennsylvania, United States|Nashville, Tennessee, United States|San Antonio, Texas, United States|Layton, Utah, United States|Vancouver, Washington, United States|Marshfield, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00802867"
109,"Comparative Study of Ceftaroline vs. Ceftriaxone in Adult Subjects With Community-Acquired Pneumonia","Completed","Has Results","Bacterial Pneumonia","Drug: Ceftaroline fosamil for Injection|Drug: IV Ceftriaxone|Drug: Placebo|Drug: Clarithromycin","Investigational site, Los Angeles, California, United States|Investigational Site, Pasadena, California, United States|Investigational Site, Sacramento, California, United States|Investigational Site, San Diego, California, United States|Investigational Site, Orlando, Florida, United States|Investigational Site, Fort Gordon, Georgia, United States|Investigational Site, Peoria, Illinois, United States|Investigational Site, Baltimore, Maryland, United States|Investigational site, Minneapolis, Minnesota, United States|Investigational Site, Butte, Montana, United States|Investigational Site, Akron, Ohio, United States|Investigational Site, Houston, Texas, United States|Investigational Site, Buenos Aires, C.a.b.a., Argentina|Investigational Site, San Miguel de Tucuman, Tucuman, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Vicente Lopez, Argentina|Investigational Site, Vienna, Austria|Investigational Site, Wien, Austria|Investigational Site, Goiania, G.o., Brazil|Investigational Site, Porto Alegre, RS, Brazil|Investigational Site, Porto Alegre, RS, Brazil|Investigational Site, Sao Jose do Rio Preto, SP, Brazil|Investigational Site 1, Belo Horizonte MG, Brazil|Investigational Site 2, Belo Horizonte, Brazil|Investigational Site, Campinas, Brazil|Investigational Site, Curitiba-PR, Brazil|Investigational Site, Juiz de Fora, Brazil|Investigational site, Porto Alegre, Brazil|Investigational Site, Sao Paolo, Brazil|Investigational Site, Sao Paolo, Brazil|Investigational Site, Burgas, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Varna, Bulgaria|Investigational Site, Tallinn, Estonia|Investigational Site, Tallinn, Estonia|Investigational Site, Tartu, Estonia|Investigational Site, Annecy, France|Investigational Site, Argenteuil, France|Investigational Site, Paris, France|Investigational Site, Paris, France|Investigational Site, Paris, France|Investigational Site, Tbilisi, Georgia|Investigational Site, Tbilisi, Georgia|Investigational Site, Lindenberger, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Bochum, Germany|Investigational Site, Bochum, Germany|Investigational Site, Erfurt, Germany|Investigational Site, Heppenheim, Germany|Investigational Site, Lich, Germany|Investigational Site, Lubeck, Germany|Investigational Site, Luedenscheid, Germany|Investigational Site, Paderborn, Germany|Investigational Site, Schkeuditz, Germany|Investigational Site, Ulm, Germany|Investigational Site, Wiesbaden, Germany|Investigational Site, Tatabanya, Szanatorium, Hungary|Investigational Site, Budapest, Hungary|Investigational Site, Matrahaza, Hungary|Investigational Site, Miskolc, Hungary|Investigational Site, Pecs, Hungary|Investigational Site, Sopron, Hungary|Investigational Site, Tatabanya, Hungary|Investigational Site, Torokbalint, Hungary|Investigational Site, Vellore, Tamilnadu, India|Investigational Site, Kaunas, Lithuania|Investigational Site, Kaunas, Lithuania|Investigational Site, Klaipeda, Lithuania|Investigational Site, Klaipeda, Lithuania|Investigational Site, Siauliai, Lithuania|Investigational Site, Vilnius, Lithuania|Investigational Site, Johor Bahru, Johor, Malaysia|Inestigational Site, Cheras, Kuala Lumpur, Malaysia|Investigational Site, Georgetown, Penang, Malaysia|Investigational Site, Kedah, Malaysia|Investigational Site, Kuala Lumpur, Malaysia|Investigational Site, Bedzin, Poland|Investigational Site, Brzesku, Poland|Investigational Site, Bytom, Poland|Investigational Site, Chodziez, Poland|Investigational Site, Czestochowa, Poland|Investigational Site, Katowice-Ochojec, Poland|Investigational Site, Krakow, Poland|Investigational Site, Lublin, Poland|Investigational Site, Lublin, Poland|Investigational Site, Poznan, Poland|Investigational Site, Poznan, Poland|Investigational Site, Tychy, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Wroclaw, Poland|Inestigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Cluj Napoca, Romania|Investigational Site, Constanta, Romania|Investigational Site, Oradea, Romania|Investigational Site, St. Brasov, Romania|Investigational Site, Targu Mures, Romania|Investigational Site, Timisoara, Romania|Investigational Site, Petrozavodsk, Republic of Karelia, Russian Federation|Investigational Site, Arkhangelsk, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Rostov-on-Don, Russian Federation|Investigational Site, Saratov, Russian Federation|Investigational Site, St Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, Tatarstan, Russian Federation|Investigational Site, Yekaterinburg, Russian Federation|Investigational Site, Yekaterinburg, Russian Federation|Investigational Site, Belgrade, Serbia|Investigational Site, Knez Selo, Serbia|Investigational Site, Kragujevac, Serbia|Investigational Site, Bratislava, Slovakia|Slovakia, Nitra-Zobor, Slovakia|Investigational Site, Bellville, Capetown, South Africa|Investigational Site, Benomi, South Africa|Investigational Site, Cape Town, South Africa|Investigational Site, Cape Town, South Africa|Investigational Site, Krugersdorp, South Africa|Investigational Site, Port Elizabeth, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Pretoria, South Africa|Investigational Site, Somerset West, South Africa|Investigational Site, Worcester, South Africa|Investigational Site, Barcelona, Spain|Investigational Site, Barcelona, Spain|Investigational Site, Elche, Spain|Investigational Site, Leon, Spain|Investigational Site, Madrid, Spain|Investigational Site, Valencia, Spain|Investigational Site, Vizcaya, Spain|Investigational Site, Biel, Switzerland|Investigational Site, Geneve, Switzerland|Investigational Site, La Chaux-de-Fonds, Switzerland|Investigational Site, Lugano, Switzerland|Investigational Site, Bangkok, Thailand|Investigational Site, Bangkok, Thailand|InvestigationalSite, Bangkok, Thailand|Investigational Site, Bangkok, Thailand|Investigational Site, Chiang Mai, Thailand|Investigational Site, Khonkaen, Thailand|Investigational Site, Nonthaburi, Thailand|Investigational Site, Aviv, Ukraine|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Donetsk, Ukraine|Investigational Site, Ivano-Frankivsk, Ukraine|Investigational Site, Kharkiv, Ukraine|Investigational Site, Kharkiv, Ukraine|Inestigational Site, Kyiv, Ukraine|Investigational Site, Kyiv, Ukraine|Investigational Site, Lugansk, Ukraine|Investigational Site, Odesa, Ukraine|Investigational Site, Poltava, Ukraine|Investigational Site, Uzhorod, Ukraine","https://ClinicalTrials.gov/show/NCT00621504"
110,"A Study of 2 Doses of Menactra®, a Meningococcal Conjugate Vaccine in Healthy Toddlers","Completed","Has Results","Meningococcal Meningitis|Measles|Mumps|Rubella|Varicella","Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate Vaccine|Biological: Meningococcal Polysaccharide Diphtheria Toxoid Conjugate","Montgomery, Alabama, United States|Fayetteville, Arkansas, United States|Jonesboro, Arkansas, United States|Little Rock, Arkansas, United States|Little Rock, Arkansas, United States|Norwich, Connecticut, United States|Cocoa Beach, Florida, United States|Viera, Florida, United States|Atlanta, Georgia, United States|Marietta, Georgia, United States|Bardstown, Kentucky, United States|Woburn, Massachusetts, United States|Bridgeton, Missouri, United States|St. Louis, Missouri, United States|Las Vegas, Nevada, United States|Rochester, New York, United States|Syracuse, New York, United States|Chapel Hill, North Carolina, United States|Goldsboro, North Carolina, United States|Laurinburg, North Carolina, United States|Sylva, North Carolina, United States|Cincinnati, Ohio, United States|Cleveland, Ohio, United States|Columbus, Ohio, United States|Tulsa, Oklahoma, United States|Pittsburgh, Pennsylvania, United States|Sellersville, Pennsylvania, United States|Kingsport, Tennessee, United States|Ft. Worth, Texas, United States|Layton, Utah, United States|Ogden, Utah, United States|Pleasant Grove, Utah, United States|Provo, Utah, United States|Salt Lake City, Utah, United States|Charlottesville, Virginia, United States|Midlothian, Virginia, United States|Norfolk, Virginia, United States|Spokane, Washington, United States|La Crosse, Wisconsin, United States","https://ClinicalTrials.gov/show/NCT00384397"
111,"Regimen for the Treatment of Cachexia in Subjects With NSCLC","Completed","Has Results","Cachexia","Drug: VT-122 low dose|Drug: VT-122 high dose","First Dynamic Health Care Services, Inc., Waco, Texas, United States|Rajalakshmi Nursing Home, Bangalore, India|Nizam Institute of Medical Sciences, Hyderabaad, India|Orchid Nursing Home, Kolkata, India|Shatabdi Super Specialty Hospital, Nashik, India|All India Institute of Medical Sciences, New Delhi, India|Indraprastha Apollo Hospital, New Delhi, India|Deenanath Mangeshkar Hospital, Pune, India","https://ClinicalTrials.gov/show/NCT00527319"
112,"Comparative Study of Ceftaroline vs. Ceftriaxone in Adults With Community-Acquired Pneumonia","Completed","Has Results","Bacterial Pneumonia","Drug: Ceftaroline fosamil for Injection|Drug: Ceftriaxone|Drug: Placebo","Investigational Site, Durham, North Carolina, United States|Investigational Site, Autonoma, Buenos Aires, Argentina|Investigational Site, Mar del Plata, Buenos Aires, Argentina|Investigational Site, Merlo, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Investigational Site, Buenos Aires, Argentina|Invetigational Site, Buenos Aires, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|INvestigational Site, Cordoba, Argentina|Investigational Site, Cordoba, Argentina|Investigational Site, Entre Rios, Argentina|Investigational Site, Granadero Baiggoria, Argentina|Investigational Site, Parana, Argentina|Investigational Site, Santa Fe, Argentina|Investigational Site, Santa Fe, Argentina|Investigational site, Grieskirchner, Wels, Austria|Investigational Site, Steyr, Austria|Investigational Site, Wels, Austria|Investigational Site, Wien, Austria|Investigational Site, Plovdiv, Bulgaria|Investigational Site, Rousse, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Site, Sofia, Bulgaria|Investigational Drug, Varna, Bulgaria|Investigational Site, San Ignacio, Valparaiso, Chile|Investigational Site, Santiago, Chile|Investigational Site, Santiago, Chile|Investigational Site, Santiago, Chile|Investigational Site, Talcahuano, Chile|Investigational Site, Temuco, Chile|Inestigational Site, Valdivia, Chile|Investigational Site, Valdivia, Chile|Investigational Site, Valparaiso, Chile|Investigational Site, Aachen, Germany|Investigational Site, Aachen, Germany|Investigational Site, Berlin, Germany|Inestigational Site, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Berlin, Germany|Investigational Site, Dachau, Germany|Investigational Site, Frankfurt am Main, Germany|Investigational Site, Frankfurt, Germany|Investigational Site, Greifswald, Germany|Investigational Site, Halle/Saale, Germany|Investigtional Site, Hannover, Germany|Investigational Site, Heidelberg, Germany|Investigational Site, Hofheim, Germany|Investigational Site, Immenhausen, Germany|Investigational Site, Lubeck, Germany|Investigational Site, Rotenburg (Wuemme), Germany|Investigational Site, Rotenburg, Germany|Investigational Site, Wuppertal, Germany|Investigational Site, Gyor, Hungary|Investigational Site, Nyiregyhaza, Hungary|Investigational Site, Nyiregyhaza, Hungary|Investigational Site, Seregelyesi, Hungary|Investigational Site, Sostoi, Hungary|Investigational Site, Szekesfehervar, Hungary|Investigational Site, Szent Instvan, Hungary|Investigational Site, Vasvari Pal, Hungary|Investigational Site, Bangalore, India|Investigational Site, Gujarat, India|Investigational Site, Karnataka, India|Investigational Site, Karnataka, India|Investigational Site, Noida, India|Investigational Site, Pradesh, India|Investigational Site, Daugavpils, Latvia|Investigational Site, Latvia, Latvia|Investigational Site, Liepaja, Latvia|Investigational Site, Riga, Latvia|Investigational Site, Chihuahua, Mexico|Investigational Site, Chihuahua, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Jalisco, Mexico|Investigational Site, Lima, Mexico|Investigational Site, Sonora, Mexico|Investigational Site, Lima, Peru|Investigational Site, Lima, Peru|Investigator Site, Bialystok, Poland|Investigational Site, Bystra, Poland|Investigational Site, Chrzanow, Poland|Investigational Site, Krakow, Poland|Investigational Site, Krakow, Poland|Investigtional Site, Krakow, Poland|Investigational Site, Krakow, Poland|Investigational Site, Lodz, Poland|Investigational Site, Lodz, Poland|Investigational Site, Lublin, Poland|Investigational Site, Poznan, Poland|Investigational Site, Poznan, Poland|Investigational Site, Skierniewice, Poland|Inestigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Warszawa, Poland|Investigational Site, Wilkowice-Bystra, Poland|Investigational Site, Wroclaw, Poland|Investigational Site, Zabrze, Poland|Investigational Site, Zabrze, Poland|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Bucharest, Romania|Investigational Site, Craiova, Romania|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Moscow, Russian Federation|Investigational Site, Smolensk, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, St. Petersburg, Russian Federation|Investigational Site, ST. Petersburg, Russian Federation|Investigational Site, Yaroslavl, Russian Federation|Investigational Site, Dnipropetrovsk, Ukraine|Investigational Site, Kharkiv, Ukraine|Investigational site, Kyiv, Ukraine|Investigational Site, Kyiv, Ukraine|Investigational site, Kyiv, Ukraine|Investigational Site, Vinnytsya, Ukraine|Investigational Site, Zaporizhya, Ukraine|Investigational Site, Zhytomyr, Ukraine","https://ClinicalTrials.gov/show/NCT00509106"
